Breast Cancer

What We're Reading: RWE Finds Pfizer, Moderna Vaccines Highly Effective; Signs of COVID-19 Surge; Lawsuit Threatens Free Preventive Care

March 30th 2021, 3:00pm


The Pfizer and Moderna COVID-19 vaccines were shown to be 90% effective in preventing infection in a real-world setting; Biden administration urges states to pause reopening plans amid signs of COVID-19 surge; a lawsuit seeks to end the requirement that preventive services be provided free of charge to Americans.

What We’re Reading: COVID-19 Screening Guidance; Eli Lilly Verzenio Results; Long-Haul Symptom Improvement

March 17th 2021, 2:24pm


The FDA issues updated guidance on the emergency use authorization (EUA) process for COVID-19 screening tools; Eli Lilly releases patient-reported outcome results for Verzenio (abemaciclib) in breast cancer; COVID-19 vaccines possibly improve long-haul symptoms among patients.

As Mammography Screenings Drop, Advanced Breast Cancer Cases Increase in First Months of COVID-19

February 15th 2021, 8:00pm


The study, presented at the 2020 San Antonio Breast Cancer Symposium, also found that time to first treatment dropped during this period of the coronavirus disease 2019 (COVID-19) pandemic.

A Cue-to-Action Pilot Project to Increase Screening Mammography

February 8th 2021, 5:00pm


A targeted cue-to-action campaign of outreach, education, and incentive can improve uptake of screening mammography.

Mental Illness May Predispose Women With Breast Cancer to Higher Mortality

January 19th 2021, 10:24pm


Severe mental illnesses that precede a breast cancer diagnosis may increase the risk of both all-cause and cancer-specific mortality among women with Medicaid coverage.

Dr Alexey Aleshin Discusses Lingering Struggles in Pinpointing Biomarkers for Breast Cancer Reoccurrence

January 13th 2021, 2:00pm


Alexey Aleshin, MD, senior medical director of Oncology at biotech giant Natera, said that attention on finding biomarkers for metastatic reoccurrence needs to be directed at women with a high risk of this happening.

Researchers Identify Possible Source of Inflammatory Response Disparity in Black, White Women With Breast Cancer

January 11th 2021, 9:20pm


A more aggressive tumor microenvironment may be to blame for the exaggerated inflammatory response more often seen in Black women with breast cancer compared with White women.

Dr Alexey Aleshin: Persistent ctDNA Is Highly Predictive of Disease Outcome

January 9th 2021, 2:00pm


Changes in circulating tumor DNA (ctDNA) are indicative of treatment response in early-stage breast cancer, pointed out Alexey Aleshin, MD, senior medical director of Oncology at biotech giant Natera.

Risk Factors Identified for Chronic Opioid, Benzodiazepine Use After Mastectomy and Breast Reconstruction

January 4th 2021, 9:02pm


An abstract from last month’s San Antonio Breast Cancer Symposium identifies factors linked with longer-term controlled substance use after treatment of breast cancer with mastectomy plus breast reconstruction in women receiving opioids, benzodiazepines, and other sedative/hypnotics.

Dr Alexey Aleshin: Chemotherapy Is Meant to Eliminate, Reduce Disease Burden

January 1st 2021, 2:00pm


Through neoadjuvant chemotherapy we can downstage tumors, assess drug efficacy, and better segregate women by prognosis status for adjuvant treatment, explained Alexey Aleshin, MD, senior medical director of Oncology at biotech giant Natera.